386 filings
Page 3 of 20
CORRESP
kk4ve acnd1
31 May 23
Correspondence with SEC
12:00am
CORRESP
j7667q2i2i71anexmbn
31 May 23
Correspondence with SEC
12:00am
CORRESP
0kd07
24 May 23
Correspondence with SEC
12:00am
CORRESP
zy7t evcexl6231
24 May 23
Correspondence with SEC
12:00am
CORRESP
adhxdwmsx416o
23 May 23
Correspondence with SEC
12:00am
FWP
2vuf6hy53zycrj
15 May 23
Free writing prospectus
5:18pm
8-K
1zo4bmigb20f1dj40k
9 May 23
Kiora Pharmaceuticals Reports First Quarter Results; Positive Clinical Data Driving Significant Progress Advancing Pipeline of Eye Disease Treatments
7:02am
UPLOAD
c7kt5jzx ifznmo
9 May 23
Letter from SEC
12:00am
8-K
9y5xho6mj0nzk
27 Apr 23
Other Events
2:55pm
8-K
fmib82r04myf0fjh2u
30 Mar 23
Changes in Registrant's Certifying Accountant
7:02am
8-K
f9ugvcmttdc7q maqr
23 Mar 23
Kiora Pharmaceuticals Reports 2022 Financial Results; Provides Update on Clinical Development Progress
7:03am
D
ymeabiky
17 Feb 23
$200.00 k in equity / options / securities to be acquired, sold $200.00 k, 1 investor
4:32pm
D
27h6hkiuvx1q5je4
17 Feb 23
$10.00 mm in equity, 1 investor
4:31pm
424B3
da5d kia8jn
13 Feb 23
Prospectus supplement
4:47pm